CG
RBOT

Cutler Group’s Vicarious Surgical RBOT Stock Holding History

Cutler Group’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-303
Closed -$37K – 5535
2022
Q1 		$46K Sell
303
-384
-56% -$71.4K ﹤0.01% 2316
2021
Q4 		$218K Buy
+687
New +$242K 0.01% 1248

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
HVCM
Hel Ved Capital Management Central, Hong Kong $844M AUM 191.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cutler Group's RBOT Position: Q2 2022 in Review

Cutler Group sold out of Vicarious Surgical (RBOT) in Q2 2022, closing a stake of 303 shares — an estimated $37K sold.

Cutler Group first reported a position in RBOT in Q4 2021 and held it in 2 quarters. The position peaked at $218K in Q4 2021. 79 funds tracked by Wall St. Rank hold RBOT as of Q2 2022.

  • Cutler Group reported no remaining Vicarious Surgical position as of Q2 2022 after selling out during the quarter.
  • Cutler Group sold 303 Vicarious Surgical shares in Q2 2022, an estimated $37K.
  • Cutler Group first reported a position in Vicarious Surgical in Q4 2021 and held it in 2 quarters.
  • Cutler Group's Vicarious Surgical position peaked at $218K in Q4 2021.
  • 79 funds tracked by Wall St. Rank held Vicarious Surgical as of Q2 2022.

Based on Cutler Group's 13F filing for Q2 2022, filed 4 Aug 2022.